[Clinical study of a new preparation in the treatment of anorectal varices].
Sterectal is a new antihemorrhoidal drug which contains prednacinolone, lidocaine hidrochloride and ephedrine hidrochloride. The results of the double blind, between patient, clinical study carried out in order to detect effectiveness of Sterectal compared with placebo show that the new drug owns a more rapid onset of therapeutic activity and exhibits a greater reduction in symptom severity than placebo. Both treatments were well tolerated.
D000328:Adult; D003898:Desonide / Q000008:administration & dosage / Q000627:therapeutic use; D004338:Drug Combinations; D004341:Drug Evaluation; D004361:Drug Tolerance; D004809:Ephedrine / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006484:Hemorrhoids / Q000188:drug therapy*; D006801:Humans; D008012:Lidocaine / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D013488:Suppositories
D004338:Drug Combinations; D013488:Suppositories; D008012:Lidocaine; D004809:Ephedrine; D003898:Desonide
Studio clinico di un nuovo preparato nel trattamento delle sindromi varicose ano-rettali